Literature DB >> 12388696

Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes.

Regina B Park1, Elliot J Androphy.   

Abstract

Papillomaviruses possess small DNA genomes that encode five early (E) proteins. Transient DNA replication requires activities of the E1 and E2 proteins and a DNA segment containing their binding sites. The E6 and E7 proteins of cancer-associated human papillomavirus (HPV) transform cells in culture. Recent reports have shown that E6 and E7 are necessary for episomal maintenance of HPV in primary keratinocytes. The functions of E6 necessary for viral replication have not been determined, and to address this question we used a recently developed transfection system based on HPV31. To utilize a series of HPV16 E6 mutations, HPV31 E6 was replaced by its HPV16 counterpart. This chimeric genome was competent for both transient and stable replication in keratinocytes. Four HPV16 E6 mutations that do not stimulate p53 degradation were unable to support stable viral replication, suggesting this activity may be necessary for episomal maintenance. E7 has also been shown to be essential for episomal maintenance of the HPV31 genome. A point mutation in the Rb binding motif of HPV E7 has been reported to render HPV31 unable to stably replicate. Interestingly, HPV31 genomes harboring two of the three p53 degradation-defective E6 mutations combined with this E7 mutation were maintained as replicating episomes. These findings imply that the balance between E6 and E7 functions in infected cells is critical for episomal maintenance of high-risk HPV genomes. This model will be useful to dissect the activities of E6 and E7 necessary for viral DNA replication.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388696      PMCID: PMC136782          DOI: 10.1128/jvi.76.22.11359-11364.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.

Authors:  M N Ruesch; L A Laimins
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107.

Authors:  M C McIntyre; M N Ruesch; L A Laimins
Journal:  Virology       Date:  1996-01-01       Impact factor: 3.616

3.  Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53.

Authors:  M Scheffner; J M Huibregtse; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

4.  Single amino acid substitutions in "low-risk" human papillomavirus (HPV) type 6 E7 protein enhance features characteristic of the "high-risk" HPV E7 oncoproteins.

Authors:  B C Sang; M S Barbosa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

5.  Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells.

Authors:  S Dalal; Q Gao; E J Androphy; V Band
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

6.  Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex.

Authors:  M Arroyo; S Bagchi; P Raychaudhuri
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

7.  The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain.

Authors:  C P Mansur; B Marcus; S Dalal; E J Androphy
Journal:  Oncogene       Date:  1995-02-02       Impact factor: 9.867

8.  Telomerase activation by the E6 gene product of human papillomavirus type 16.

Authors:  A J Klingelhutz; S A Foster; J K McDougall
Journal:  Nature       Date:  1996-03-07       Impact factor: 49.962

9.  Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein.

Authors:  J J Chen; C E Reid; V Band; E J Androphy
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

10.  In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression.

Authors:  M G Frattini; H B Lim; L A Laimins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

View more
  39 in total

Review 1.  Mechanisms of human papillomavirus-induced oncogenesis.

Authors:  Karl Münger; Amy Baldwin; Kirsten M Edwards; Hiroyuki Hayakawa; Christine L Nguyen; Michael Owens; Miranda Grace; Kyungwon Huh
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 2.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

3.  Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31.

Authors:  Choongho Lee; Laimonis A Laimins
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 4.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

Review 5.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

6.  Variations in the association of papillomavirus E2 proteins with mitotic chromosomes.

Authors:  Jaquelline G Oliveira; Leremy A Colf; Alison A McBride
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-13       Impact factor: 11.205

Review 7.  Persistence of human papillomavirus infection: keys to malignant progression.

Authors:  Jason Bodily; Laimonis A Laimins
Journal:  Trends Microbiol       Date:  2010-11-01       Impact factor: 17.079

8.  Network Analysis of UBE3A/E6AP-Associated Proteins Provides Connections to Several Distinct Cellular Processes.

Authors:  Gustavo Martínez-Noël; Katja Luck; Simone Kühnle; Alice Desbuleux; Patricia Szajner; Jeffrey T Galligan; Diana Rodriguez; Leon Zheng; Kathleen Boyland; Flavian Leclere; Quan Zhong; David E Hill; Marc Vidal; Peter M Howley
Journal:  J Mol Biol       Date:  2018-02-06       Impact factor: 5.469

9.  Papillomavirus E6 PDZ interactions can be replaced by repression of p53 to promote episomal human papillomavirus genome maintenance.

Authors:  Nicole Brimer; Scott B Vande Pol
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

10.  Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein.

Authors:  Joanna Laurson; Sadaf Khan; Rachel Chung; Karen Cross; Kenneth Raj
Journal:  Carcinogenesis       Date:  2010-02-01       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.